SLC4A1 and autoimmune disease: In patients with overt dRTA, etiologic screening was profitable, with a genetic cause being identified in 42.9% of cases (N = 3) without autoimmune disease (N = 7), all having the same missense mutation in Arg589 of the SLC4A1 gene, common in Europe [6, 25].